Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion

Diabetic Medicine

Volumn 31, Issue 10, 2014, Pages 1174-1177

  Nixon, R ^a,b   Folwell, R ^a,c   Pickup, John C ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LONG TERM CARE; MALE; TREATMENT RESPONSE; ADVERSE EFFECTS; BLOOD; COHORT ANALYSIS; COMPLICATION; DIABETES MELLITUS, TYPE 1; FOLLOW UP; HEALTH CARE QUALITY; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; MEDICATION COMPLIANCE; MIDDLE AGED; OBESITY; OUTPATIENT DEPARTMENT; SUBCUTANEOUS DRUG ADMINISTRATION; UNITED KINGDOM;

ADULT; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; LONDON; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; OVERWEIGHT; QUALITY OF HEALTH CARE;

EID: 84920270045     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12486     Document Type: Article

References (12)

1. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008; 25: 765-774.
2. Bruttomesso D, Costa S, Baritutussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabet Metab Res Rev 2009; 25: 99-111.
3. Bruttomesso D, Pianta D, Crazzolara E, Scaldaferri L, Lora L, Mongillo R et al. Continuous subcutaneous insulin infusion (CSII) in the Vento region: efficay, acceptability and quality of life. Diabet Med 2002; 19: 628-634.
4. Garmo A, Garmo H, Årnlåv J, Leksell J. Long-term treatment effects of insulin pump therapy. Pract Diabet 2011; 28: 295-299.
5. Hughes CR, McDowell N, Cody D, Costigan C. Sustained benefits of continuous subcutaneous insulin infusion. Arch Dis Child 2012; 97: 245-247.
6. Carlsson B-M, Atvall S, Clements M, Grumpeny SR, Pivodic A, Sternemalm L et al. Insulin pump - long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden. Diabetes Technol Ther 2013; 15: 302-307.
7. Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome on insulin pump therapy in children with type 1 diabetes in a large population-based case-control study. Diabetologia 2013; 56: 2392-2400.
8. NICE. Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. Technology appraisal guidance 151 (review of technology appraisal guidance 57). London: National Institute for Health and Clinical Excellence, 2008.
9. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987; 10: 617-621.
10. Nixon R, Pickup JC. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control? Diabetes Technol Ther 2011; 13: 93-98.
11. Aberle I, Scholz U, Bach-Kliegel B, Fischer C, Gorny M, Langer K et al. Psychological aspects in continuous subcutaneous insulin infusion: a retrospective study. J Psychol 2009; 14: 147-160.
12. 1c measurement and gaols for improvement: from chaos to order for improving diabetes care. Clin Chem 2011; 57: 205-214.